newsfilter
← Interviews
80,000 Hours2h 20m

The cutting edge of anti-ageing science | Venki Ramakrishnan

Venki Ramakrishnan, Luisa Rodriguez

Interview, Podcast

Recent discourse identifies a biological "hard limit" near 110 for human lifespan, driven by evolutionary trade-offs that prioritize reproduction over somatic repair rather than external disease mortality. While interventions like senolytics, cellular reprogramming, and TOR pathway inhibition show promising results in extending healthspan in model organisms, significant safety hurdles and the complexity of reversing brain aging prevent immediate human application. Experts warn that successful longevity therapies will likely exacerbate existing economic inequalities and necessitate profound societal shifts in workforce dynamics and retirement structures to manage an expanded elderly demographic.